Danish Biotech Stock News

ISS (CPSE:ISS) drew investor attention after reporting half year 2026 results, reaffirming its full year earnings guidance and expanding its share buyback authorization. The update combined operational data with a clearer view of capital returns. See our latest analysis for ISS. The latest earnings update and larger buyback sit against a share price of DKK292.0, with a 90 day share price return of 10.19% and a year to date share price return of 35.44%. Over longer horizons, total shareholder...

North Media entered this earnings day as a value puzzle. The stock trades on a P/E of 4.5x against a European media peer group closer to the mid teens, yet the share price slipped around the Q2 release, with a 7 day return of roughly 3% down. The headline is simple: Q2 2026 delivered a sharp swing back into profit with basic earnings per share of DKK7.6 on net income of DKK137.1 million. The market is weighing that against questions on earnings quality and a discounted cash flow value that...

Why Demant’s latest earnings and product launch matter for investors Demant (CPSE:DEMANT) has just paired half year 2026 earnings, with higher sales and net income, and launched Oticon Reveal, a new AI powered rechargeable hearing aid, putting both financial and product performance in focus. See our latest analysis for Demant. At a share price of DKK286.0, Demant has seen a 15.70% 90 day share price return and a 34.02% year to date share price return, while the 5 year total shareholder return...

TCM Group stock closed at DKK67.6 on Friday, capping a run of weak short term returns with the shares down about 3% over both one month and three months. Yet behind that soft tape sits a kitchen maker that just printed Q2 revenue of DKK374.8m and kept full year guidance intact. The real story is not the quarter’s modest earnings per share of DKK1.61. It is a business leaning on free cash flow and margin repair to support a low 9.3x trailing P/E and a balance sheet carrying high debt. The next...

Gubra stock has been on a tear in recent months, closing at DKK390.2 and sitting on a double digit gain over 30 and 90 days. Yet the fresh H1 2026 report tells a tougher story on the income statement, with revenue of DKK126.3m sitting beside a net loss of DKK110.0m. The real headline is not this half year loss. It is the tension between heavy investment in obesity and peptide drug discovery on one side and a valuation that already prices in a lot of future success on the other. Short term...

SP Group stock has barely moved over the past month, yet the latest earnings land with far more force than the share price suggests. You are looking at a company trading on a P/E of 16.8x while delivering record first half 2026 results and a trailing net margin of 9.7%. The real story sits beyond today’s tick-by-tick moves. Revenue is running close to DKK 3.4b on a trailing twelve month basis, and earnings over the past year are reported up 32.4%. For long term holders, the question is how...

cBrain arrived at this earnings print with a strong recent share run and a valuation that already reflected high growth expectations. The stock closed at DKK74 after the report, leaving investors to weigh a familiar software trade off. Revenue for H1 2026 came in at DKK140.0m with net income of DKK27.9m, while the trailing 12 month net margin sits at 18.1%, below the prior year level. The central question is whether that margin pressure reflects a temporary investment choice or a more...

Dampskibsselskabet Norden (CPSE:DNORD) drew fresh attention after reporting second quarter 2026 sales of US$1,047.4 million and net income of US$100.8 million, alongside a higher floor for its full year net profit guidance. See our latest analysis for Dampskibsselskabet Norden. The strong second quarter update and raised guidance appear to sit behind a clear upswing in Dampskibsselskabet Norden's share price, with a 6.45% 1 month share price return and a 39.66% year to date share price...

A week ago, FLSmidth & Co. A/S ( CPH:FLS ) came out with a strong set of quarterly numbers that could potentially lead...

The quarterly results for Coloplast A/S ( CPH:COLO B ) were released last week, making it a good time to revisit its...

ALK-Abelló stock went into the earnings release under pressure, down roughly 20% over the past three months, yet the latest numbers tell a more resilient story. The company just posted trailing twelve month revenue of DKK 6,561m and earnings from continuing operations of DKK 1,280m, with a net profit margin near 19.5%. The key question for you now is whether that profit profile justifies a P/E of about 36x in a sector where many peers trade at far lower multiples. The rest of the earnings...

GN Store Nord stock came into this earnings print under pressure, down about 12% over the past week and weaker over the past quarter as well. The headline from Q2 is not a growth story. The group booked a loss from continuing operations and reported basic earnings per share of DKK 1.56 in the red, even though revenue from continuing operations reached DKK 2,171m. The key issue for investors is the balance sheet and valuation strain. Net interest bearing debt of DKK 9.6b remains heavy, while...

Columbus stock closed at DKK9.8 heading into the first full trading day after its earnings release, with recent returns only slightly in the red over one, three and six months. The headline from the numbers is not growth. It is the squeeze on profitability. Trailing net profit margin is 0.4% compared with 2.9% a year earlier, and earnings in the most recent year turned negative, even as revenue stayed in the billion-krona range. For an IT services company, that gap between volume and profit...

The market came into GrønlandsBANKEN’s Q2 numbers with the stock drifting, down about 7% over the past month and slightly weaker over the past week. Yet the headline from these results is not the share price; it is the squeeze on profitability in a bank already wrestling with elevated bad loans. Revenue for Q2 landed at DKK 117.429 million while net income came in at DKK 45.864 million, well below the strong Q1 run rate. For a bank often viewed through a value lens, with a P/E of 10.4x and a...

The market has barely flinched on Lån & Spar Bank, with the stock almost flat over the last month despite a clear earnings jolt in Q2. Basic earnings per share jumped to DKK36.80 as net income reached DKK127.21m, putting profit strength at the center of this release. For a bank already trading on a P/E of 11.3x and priced well below some valuation estimates, that level of profitability sets up a sentiment clash. Short term price action looks cautious, while the Q2 numbers highlight an...

Lollands Bank comes into this earnings season with a stock that has been quietly grinding higher, up about 2.1% over the past week and 2.5% over three months, while trading on a modest P/E of 10.4x. The headline from Q2 is simple: profitability is the story. Net profit margins over the last year sit at 30.8% compared with 29.5% a year earlier, and earnings have risen 3.3% over that period. For a regional bank, that margin profile is the key tension between the muted share price moves and what...

Novozymes stock went into today on a strong run, with the share price up about 17% over the past three months and trading on a rich P/E near 45x. That kind of optimism sets a high bar. The earnings headline is clear. Organic sales in the first half grew 8% with adjusted earnings before interest, tax, depreciation and amortization margin at 37.7%, and management lifted full year organic growth guidance to 7 to 8% with margin expected at the top of the 37 to 38% range. Is Novozymes at 45x P/E a...

Carlsberg stock has drifted lower in recent weeks, with the share price down about 7% over the past month even as H1 results landed with solid headline growth. The earnings story that matters most is not the revenue print. It is the squeeze on profitability that shows up in a trailing net margin of 7.1% compared with 8.1% a year earlier. Short term traders are reacting to the chart. Long term holders are more likely focused on a company that still carries a premium P/E multiple and high debt,...

Kreditbanken entered this earnings day with a strong equity story in the bank sector. The stock closed at DKK9,750 on 20 August after a solid run over the past quarter, and the fresh Q2 numbers show that the real action is in the income statement, not the chart. The headline is profitability. Net income for Q2 came in at DKK40.5 million on revenue of DKK101.6 million, while trailing 12 month net profit margin sits at 41%. For a stock trading on a trailing P/E of 11.1x, that combination of...

UIE went into this earnings print with a market profile that looked confused. The stock closed at DKK391 on 20 August, with a rich 21.1x P/E and yet a discount to a much higher cash flow valuation. That tension met a quarter where the headline story is profit quality rather than breakneck growth. Q2 2026 basic earnings per share landed at US$1.21 on net income of US$37.17m, a clean rebound from the loss in Q1. For you as an investor, the question now is how durable that margin recovery really...

The market has cooled on H. Lundbeck in recent months, with the stock down about 5% over 30 days and closing at DKK40.64 yesterday, even as the long term story has often centered on underappreciated value. Q2 2026 results land squarely in that expectation gap. Revenue of DKK6,463m and basic earnings per share of DKK1.16 tell a quieter quarterly story, yet the trailing P/E of 10.2x versus far higher industry averages and a discounted cash flow value estimate above DKK100 keep the valuation...

Rockwool stock has been treading water in recent weeks, roughly flat over one and three months. The latest earnings reminder is blunt: the company is still loss making on a trailing 12 month view, even as Q2 delivered €1,009m in revenue and €93m in net income from ongoing operations. The short term story is a stock that already trades on a rich sales multiple and sits well above a cited discounted cash flow value. The longer term question for you is whether the expected earnings recovery can...

Vestas Wind Systems (CPSE:VWS) drew investor attention after reporting second quarter 2026 earnings, with higher sales and net income than a year earlier, while also raising EBIT margin guidance for the full year. See our latest analysis for Vestas Wind Systems. The earnings release and raised margin outlook appear to be contributing to building momentum in Vestas Wind Systems, with a 30 day share price return of 15.19% and a 1 year total shareholder return of 56.28% from a lower base, even...

Trifork Group AG ( CPH:TRIFOR ) shareholders are probably feeling a little disappointed, since its shares fell 9.8% to...